Company
Oncocyte Corporation (NASDAQ:OCX) Down Almost -19.54% In 1 Month, Long Term Looking Good As Well
In last trading session, Oncocyte Corporation (NASDAQ:OCX) saw 0.33 million shares changing hands with its beta currently measuring 0.94. Company’s recent per share price level
